Article thumbnail

Tumour suppressor ING1b maintains genomic stability upon replication stress

By Ronald P. C. Wong, Hanyang Lin, Shahram Khosravi, Brad Piche, Seyed Mehdi Jafarnejad, David W. C. Chen and Gang Li


The lesion bypass pathway, which is regulated by monoubiquitination of proliferating cell nuclear antigen (PCNA), is essential for resolving replication stalling due to DNA lesions. This process is important for preventing genomic instability and cancer development. Previously, it was shown that cells deficient in tumour suppressor p33ING1 (ING1b) are hypersensitive to DNA damaging agents via unknown mechanism. In this study, we demonstrated a novel tumour suppressive function of ING1b in preserving genomic stability upon replication stress through regulating PCNA monoubiquitination. We found that ING1b knockdown cells are more sensitive to UV due to defects in recovering from UV-induced replication blockage, leading to enhanced genomic instability. We revealed that ING1b is required for the E3 ligase Rad18-mediated PCNA monoubiquitination in lesion bypass. Interestingly, ING1b-mediated PCNA monoubiquitination is associated with the regulation of histone H4 acetylation. Results indicate that chromatin remodelling contributes to the stabilization of stalled replication fork and to the regulation of PCNA monoubiquitination during lesion bypass

Topics: Genome Integrity, Repair and Replication
Publisher: Oxford University Press
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2008). Activation of ubiquitin-dependent DNA damage bypass is mediated by replication protein a.
  2. (2004). Cellular machineries for chromosomal DNA repair.
  3. (1998). Chemotherapy-induced apoptosis in melanoma cells is p53 dependent.
  4. (2007). Chromatin challenges during DNA replication and repair.
  5. (2001). Chromosomal stability and the DNA double-stranded break connection.
  6. (2007). Cleavage of the transactivation-inhibitory domain of p63 by caspases enhances apoptosis.
  7. (2003). Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation.
  8. (2010). CRL4(Cdt2) E3 ubiquitin ligase monoubiquitinates PCNA to promote translesion DNA synthesis.
  9. (2007). Deletion of p37Ing1 in mice reveals a p53-independent role for Ing1 in the suppression of cell proliferation, apoptosis, and tumorigenesis.
  10. (2001). Differential association of products of alternative transcripts of the candidate tumor suppressor
  11. (2004). DNA replication fidelity.
  12. (2000). Dysfunction of human Rad18 results in defective postreplication repair and hypersensitivity to multiple mutagens.
  13. (2008). Effect of proliferating cell nuclear antigen ubiquitination and chromatin structure on the dynamic properties of the Y-family DNA polymerases.
  14. (2003). Enhanced genomic instability and defective postreplication repair in RAD18 knockout mouse embryonic stem cells.
  15. (2007). Evidence that in xeroderma pigmentosum variant cells, which lack DNA polymerase eta, DNA polymerase iota causes the very high frequency and unique spectrum of UV-induced mutations.
  16. (1994). Fine mapping of a replication origin of human DNA.
  17. (1997). Genetic instability in colorectal cancers.
  18. (2002). Human ING1 proteins differentially regulate histone acetylation.
  19. (2006). ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.
  20. (2009). ING2 controls the progression of DNA replication forks to maintain genome stability.
  21. (2008). Ino80 chromatin remodeling complex promotes recovery of stalled replication forks.
  22. (2004). Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage.
  23. (2009). Involvement of a chromatin remodeling complex in damage tolerance during DNA replication.
  24. (2006). Lysine 63-polyubiquitination guards against translesion synthesis-induced mutations.
  25. (2006). Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2.
  26. (1998). Mutations of mitotic checkpoint genes in human cancers.
  27. (2002). NuA4 subunit Yng2 function in intra-S-phase DNA damage response.
  28. (2002). p33(ING1) enhances UVB-induced apoptosis in melanoma cells.
  29. (2007). Phosphorylation of the tumor suppressor p33(ING1b) at Ser-126 influences its protein stability and proliferation of melanoma cells.
  30. (2004). Rad18 guides poleta to replication stalling sites through physical interaction and PCNA monoubiquitination.
  31. (2002). RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO.
  32. (2008). Regulation of proliferating cell nuclear antigen ubiquitination in mammalian cells.
  33. (2010). Regulation of translesion synthesis DNA polymerase eta by monoubiquitination.
  34. (2003). Replication of a cis-syn thymine dimer at atomic resolution.
  35. (2008). Roles of PCNA-binding and ubiquitin-binding domains in human DNA polymerase eta in translesion DNA synthesis.
  36. (2009). SharING out the roles in replicatING DNA.
  37. (2004). Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans.
  38. (2001). Structure of the catalytic core of S. cerevisiae DNA polymerase eta: implications for translesion DNA synthesis.
  39. (2006). Targeted disruption of the mouse ing1 locus results in reduced body size, hypersensitivity to radiation and elevated incidence of lymphomas.
  40. (1998). The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.
  41. (2011). The ING family tumor suppressors: from structure to function. Cell Mol.
  42. (2007). The ING1b tumor suppressor facilitates nucleotide excision repair by promoting chromatin accessibility to XPA.
  43. (2008). The Ino80 chromatin-remodeling enzyme regulates replisome function and stability.
  44. (2009). The p400/Tip60 ratio is critical for colorectal cancer cell proliferation through DNA damage response pathways.
  45. (2005). The RAD6 pathway: control of DNA damage bypass and mutagenesis by ubiquitin and SUMO.
  46. (2009). The role of ING tumor suppressors in UV stress response and melanoma progression.
  47. (2006). to active gene repression.
  48. (2006). Translesion synthesis in mammalian cells.
  49. (2007). Translesion synthesis: Y-family polymerases and the polymerase switch.
  50. (2005). Ubiquitinated proliferating cell nuclear antigen activates translesion DNA polymerases eta and REV1.
  51. (2002). UV-induced replication arrest in the xeroderma pigmentosum variant leads to DNA double-strand breaks, gamma-H2AX formation, and Mre11 relocalization.
  52. (2001). Xeroderma pigmentosum– bridging a gap between clinic and laboratory.